PRA (PRAA) 10-Q 7 Aug 24 2024 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2024	Aug. 01, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	000-50058
Entity Registrant Name	PRA Group, Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-3078675
Entity Address, Address Line One	120 Corporate Boulevard
Entity Address, City or Town	Norfolk
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	23502
City Area Code	888
Local Phone Number	772-7326
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	PRAA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		39,417,253
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001185348

Recently Issued Accounting Stan

Recently Issued Accounting Standards	6 Months Ended
	Jun. 30, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recently Issued Accounting Standards	Recently Issued Accounting Standards: Recently issued accounting standards not yet adopted: In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07"), which, among other updates, requires enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker, as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. Early adoption is permitted. In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09"), which requires enhanced annual disclosures with respect to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is currently evaluating both ASU 2023-07 and ASU 2023-09 to determine the impacts on its disclosures.

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Assets [Abstract]
Cash and Cash Equivalents, at Carrying Value	$ 118,865	$ 112,528
Investments	59,619	72,404
Financing Receivable, after Allowance for Credit Loss, Current	3,820,186	3,656,598
Income Taxes Receivable, Current	34,813	27,713
Deferred Income Tax Assets, Net	76,486	74,694
Operating Lease, Right-of-Use Asset	42,374	45,877
Property, Plant and Equipment, Net	32,827	36,450
Goodwill	415,646	431,564
Other Assets	61,124	67,526
Assets, Total	4,661,940	4,525,354
Liabilities [Abstract]
Accounts Payable	10,198	6,325
Accrued Liabilities	114,260	131,893
Accrued Income Taxes	23,583	17,912
Deferred Tax Liabilities, Net, After Adjustments	18,423	17,051
Operating Lease, Liability	46,746	50,300
Interest-Bearing Deposit Liabilities	114,991	115,589
Debt, Long-Term and Short-Term, Combined Amount	3,113,777	2,914,270
Other Liabilities, Current	16,684	32,638
Liabilities, Total	3,458,662	3,285,978
Equity, Attributable to Parent [Abstract]
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Outstanding	394	392
Additional Paid in Capital, Common Stock	12,339	7,071
Retained Earnings (Accumulated Deficit)	1,514,539	1,489,548
Accumulated Other Comprehensive Income (Loss), Net of Tax	(381,809)	(329,899)
Equity, Attributable to Parent, Total	1,145,463	1,167,112
Equity, Attributable to Noncontrolling Interest	57,815	72,264
Equity, Including Portion Attributable to Noncontrolling Interest, Total	1,203,278	1,239,376
Liabilities and Equity, Total	$ 4,661,940	$ 4,525,354

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	39,417,000	39,247,000
Common stock, shares outstanding	39,417,000	39,247,000

Consolidated Income Statements

Consolidated Income Statements - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues:
Financing Receivable, Allowance For Credit Losses, Recoveries Reclassified To Income	$ 209,290	$ 184,290	$ 411,346	$ 372,532
Financing Receivable, Allowance For Credit Loss, Changes In Estimated Recoveries	73,320	21,136	124,994	(15,776)
Financing Receivable, Allowance For Credit Loss, Portfolio Revenue	282,610	205,426	536,340	356,756
Revenue From Contract With Customer And Fee Revenue, Excluding Assessed Tax	1,619	3,810	3,475	7,950
Revenues, Total	284,229	209,236	539,815	364,706
Operating Expenses [Abstract]
Labor and Related Expense	74,241	65,788	147,838	148,191
Legal Fees	13,762	9,551	25,874	18,389
Legal Costs	35,274	21,522	61,965	45,467
Agency Fees	21,008	17,677	40,731	35,055
Outside Fees And Services Expenses	18,124	18,262	43,174	43,206
Communication	11,577	10,117	24,155	20,644
Rent And Occupancy	4,136	4,319	8,280	8,767
Depreciation, Depletion and Amortization, Nonproduction	2,637	3,482	5,357	7,071
Other Cost and Expense, Operating	14,248	12,957	26,823	25,999
Operating Expenses, Total	195,007	163,675	384,197	352,789
Operating Income (Loss), Total	89,222	45,561	155,618	11,917
Interest Income (Expense), Nonoperating	(55,353)	(43,022)	(107,631)	(81,305)
Nonoperating Income (Expense) [Abstract]
Interest Income (Expense), Nonoperating	(55,353)	(43,022)	(107,631)	(81,305)
Gain (Loss), Foreign Currency Transaction, before Tax	(99)	429	128	420
Other Nonoperating Income (Expense)	46	(230)	(160)	(880)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	33,816	2,738	47,955	(69,848)
Income Tax Expense (Benefit)	8,702	1,578	11,088	(17,105)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total	25,114	1,160	36,867	(52,743)
Net Income (Loss) Attributable to Noncontrolling Interest	3,598	4,964	11,876	9,690
Net Income (Loss) Attributable to Parent, Total	$ 21,516	$ (3,804)	$ 24,991	$ (62,433)
Earnings Per Share [Abstract]
Basic (in dollars per share)	$ 0.55	$ (0.10)	$ 0.64	$ (1.60)
Diluted (in dollars per share)	$ 0.54	$ (0.10)	$ 0.63	$ (1.60)
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic (shares)	39,364	39,190	39,319	39,111
Diluted (shares)	39,546	39,190	39,497	39,111

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 25,114	$ 1,160	$ 36,867	$ (52,743)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax	(14,258)	7,083	(62,449)	5,533
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(1,293)	5,719	1,515	888
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax	65	(80)	111	48
Other Comprehensive Income (Loss), Net of Tax, Total	(15,486)	12,722	(60,823)	6,469
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total	9,628	13,882	(23,956)	(46,274)
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest	(3,097)	8,956	2,962	16,232
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total	$ 12,725	$ 4,926	$ (26,918)	$ (62,506)

Consolidated Statement of Chang

Consolidated Statement of Changes in Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive (Loss)	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2022		38,980,000
Beginning balance at Dec. 31, 2022	$ 1,286,750	$ 390	$ 2,172	$ 1,573,025	$ (347,926)	$ 59,089
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	(53,903)			(58,629)		4,726
Currency translation adjustments	(1,550)				(4,101)	2,551
Cash flow hedges	(4,831)				(4,831)
Debt securities available-for-sale	128				128
Vesting of restricted stock (in shares)		190,000
Vesting of restricted stock		$ 2	(2)
Share-based compensation expense	3,799		3,799
Employee stock relinquished for payment of taxes	(5,684)		(5,684)
Ending balance (in shares) at Mar. 31, 2023		39,170,000
Ending balance at Mar. 31, 2023	1,224,709	$ 392	285	1,514,396	(356,730)	66,366
Beginning balance (in shares) at Dec. 31, 2022		38,980,000
Beginning balance at Dec. 31, 2022	1,286,750	$ 390	2,172	1,573,025	(347,926)	59,089
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash flow hedges	888
Debt securities available-for-sale	48
Changes in estimated recoveries	(15,776)
Ending balance (in shares) at Jun. 30, 2023		39,242,000
Ending balance at Jun. 30, 2023	1,239,674	$ 392	2,541	1,510,592	(348,000)	74,149
Beginning balance (in shares) at Mar. 31, 2023		39,170,000
Beginning balance at Mar. 31, 2023	1,224,709	$ 392	285	1,514,396	(356,730)	66,366
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,160			(3,804)		4,964
Currency translation adjustments	7,083				3,091	3,992
Cash flow hedges	5,719				5,719
Debt securities available-for-sale	(80)				(80)
Changes in estimated recoveries	21,136
Distributions to noncontrolling interest	(1,173)					(1,173)
Vesting of restricted stock (in shares)		72,000
Vesting of restricted stock		$ 0	0
Share-based compensation expense	2,715		2,715
Employee stock relinquished for payment of taxes	(459)		(459)
Ending balance (in shares) at Jun. 30, 2023		39,242,000
Ending balance at Jun. 30, 2023	$ 1,239,674	$ 392	2,541	1,510,592	(348,000)	74,149
Beginning balance (in shares) at Dec. 31, 2023	39,247,000	39,247,000
Beginning balance at Dec. 31, 2023	$ 1,239,376	$ 392	7,071	1,489,548	(329,899)	72,264
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	11,753			3,475		8,278
Currency translation adjustments	(48,191)				(45,973)	(2,218)
Cash flow hedges	2,808				2,808
Debt securities available-for-sale	46				46
Distributions to noncontrolling interest	(11,332)					(11,332)
Vesting of restricted stock (in shares)		98,000
Vesting of restricted stock		$ 1	(1)
Share-based compensation expense	3,327		3,327
Employee stock relinquished for payment of taxes	(1,469)		(1,469)
Ending balance (in shares) at Mar. 31, 2024		39,345,000
Ending balance at Mar. 31, 2024	$ 1,196,318	$ 393	8,928	1,493,023	(373,018)	66,992
Beginning balance (in shares) at Dec. 31, 2023	39,247,000	39,247,000
Beginning balance at Dec. 31, 2023	$ 1,239,376	$ 392	7,071	1,489,548	(329,899)	72,264
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash flow hedges	1,515
Debt securities available-for-sale	111
Changes in estimated recoveries	$ 124,994
Ending balance (in shares) at Jun. 30, 2024	39,417,000	39,417,000
Ending balance at Jun. 30, 2024	$ 1,203,278	$ 394	12,339	1,514,539	(381,809)	57,815
Beginning balance (in shares) at Mar. 31, 2024		39,345,000
Beginning balance at Mar. 31, 2024	1,196,318	$ 393	8,928	1,493,023	(373,018)	66,992
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	25,114			21,516		3,598
Currency translation adjustments	(14,258)				(7,563)	(6,695)
Cash flow hedges	(1,293)				(1,293)
Debt securities available-for-sale	65				65
Changes in estimated recoveries	73,320
Distributions to noncontrolling interest	(6,080)					(6,080)
Vesting of restricted stock (in shares)		72,000
Vesting of restricted stock		$ 1	(1)
Share-based compensation expense	3,555		3,555
Employee stock relinquished for payment of taxes	$ (143)		(143)
Ending balance (in shares) at Jun. 30, 2024	39,417,000	39,417,000
Ending balance at Jun. 30, 2024	$ 1,203,278	$ 394	$ 12,339	$ 1,514,539	$ (381,809)	$ 57,815

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net income	$ 36,867	$ (52,743)
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Share-Based Payment Arrangement, Noncash Expense	6,882	6,514
Depreciation and amortization	5,357	7,071
Amortization of Debt Issuance Costs and Discounts	4,531	4,825
Financing Receivable, Allowance For Credit Loss, Changes In Estimated Recoveries	(124,994)	15,776
Deferred Income Taxes and Tax Credits	(2,073)	(24,439)
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax	11,215	27,907
Other Noncash Income (Expense)	(1,027)	(1,051)
Increase (Decrease) in Operating Capital [Abstract]
Increase (Decrease) in Other Operating Assets	(1,046)	(1,306)
Accrued expenses, accounts payable and other liabilities	(13,404)	6,050
Increase (Decrease) in Income Taxes	(2,366)	(13,629)
Net Cash Provided by (Used in) Operating Activities, Total	(102,488)	(80,839)
Net Cash Provided by (Used in) Investing Activities [Abstract]
Payments to Acquire Property, Plant, and Equipment	(1,832)	(1,091)
Payments to Acquire Finance Receivables	(625,186)	(559,547)
Proceeds From Recovery Of Negative Financing Receivable Allowance	520,940	463,966
Payments For (Proceeds From) Marketable Securities)	(48,247)	(60,057)
Proceeds from Sale and Maturity of Marketable Securities	58,130	62,762
Net Cash Provided by (Used in) Investing Activities, Total	(96,195)	(93,967)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Proceeds from Long-Term Lines of Credit	435,341	459,432
Repayments of Long-Term Lines of Credit	(604,938)	(274,772)
Repayments of Convertible Debt	0	(345,000)
Proceeds from Issuance of Unsecured Debt	400,000	0
Repayments of Other Long-Term Debt	(7,500)	(5,000)
Payments On Senior Notes	0	(3,657)
Payments of Financing Costs	(5,111)	(5,324)
Payment, Tax Withholding, Share-Based Payment Arrangement	(1,612)	(6,142)
Payments to Noncontrolling Interests	(17,412)	(1,172)
Net Change Interest-Bearing Deposits, Foreign	5,058	(9,869)
Net Cash Provided by (Used in) Financing Activities, Total	203,826	208,496
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	1,082	6,216
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	6,225	39,906
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance	113,692	84,759
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Ending Balance	119,917	124,665
Supplemental Cash Flow Information [Abstract]
Interest Paid, Excluding Capitalized Interest, Operating Activities	116,575	51,652
Income Taxes Paid	15,326	20,859
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]
Cash and Cash Equivalents, at Carrying Value	118,865	111,375
Restricted Cash and Cash Equivalents	1,052	13,290
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	119,917	124,665
2028 Notes
Net Cash Provided by (Used in) Financing Activities [Abstract]
Proceeds from Issuance of Other Long-Term Debt	$ 0	$ 400,000

Organization and Business

Organization and Business	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Business	Organization and Business: Nature of operations : As used herein, the terms "PRA Group," the "Company," or similar terms refer to PRA Group, Inc. and its subsidiaries. PRA Group, Inc., a Delaware corporation, is a global financial and business services company with operations in the Americas, Europe and Australia. The Company's primary business is the purchase, collection and management of portfolios of nonperforming loans. The Company also provides fee-based services on class action claims recoveries in the United States ("U.S."). Basis of presentation : The Consolidated Financial Statements of the Company are prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). The accompanying interim financial statements have been prepared in accordance with the instructions for Quarterly Reports on Form 10-Q, and therefore, do not include all information and Notes to the Consolidated Financial Statements necessary for a complete presentation of financial position, results of operations, comprehensive income/(loss) and cash flows in conformity with GAAP. In the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair presentation of the Company's Consolidated Balance Sheets as of June 30, 2024, its Consolidated Income Statements and Statements of Comprehensive Income for the three and six months ended June 30, 2024 and 2023, and its Consolidated Statements of Changes in Equity and Statements of Cash Flows for the six months ended June 30, 2024 and 2023, have been included. The Consolidated Financial Statements include the accounts of PRA Group and other entities in which the Company has a controlling interest. All significant intercompany accounts and transactions have been eliminated. These unaudited Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 (the "2023 Form 10-K"). For further discussion of the Company's significant accounting policies, refer to Note 1 to the Consolidated Financial Statements in the 2023 Form 10-K. There were no material changes to these policies during the three months ended June 30, 2024. The preparation of the Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Realized results could differ from those estimates and assumptions, and the Company's Consolidated Income Statements for the three and six months ended June 30, 2024 may not be indicative of future results. Reclassification of prior year presentation: In the Consolidated Statements of Cash Flows, certain prior period amounts have been reclassified for consistency with the current period presentation.

Finance Receivables, net

Finance Receivables, net	6 Months Ended
	Jun. 30, 2024
Receivables [Abstract]
Finance Receivables, net	Finance Receivables, net: Finance receivables, net consisted of the following as of June 30, 2024 and December 31, 2023 (amounts in thousands): June 30, 2024 December 31, 2023 Amortized cost $ — $ — Negative allowance for expected recoveries 3,820,186 3,656,598 Balance at end of period $ 3,820,186 $ 3,656,598 Changes in the negative allowance for expected recoveries by portfolio segment for the three and six months ended June 30, 2024 and 2023 were as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Balance at beginning of period $ 3,298,092 $ 352,103 $ 3,650,195 $ 2,935,850 $ 350,647 $ 3,286,497 Initial negative allowance for expected recoveries - portfolio acquisitions (1) 326,752 52,617 379,369 308,274 19,485 327,759 Foreign currency translation adjustment (13,623) 205 (13,418) 23,380 4,034 27,414 Recoveries applied to negative allowance (2) (226,247) (43,033) (269,280) (198,897) (39,361) (238,258) Changes in expected recoveries (3) 65,747 7,573 73,320 17,798 3,338 21,136 Balance at end of period $ 3,450,721 $ 369,465 $ 3,820,186 $ 3,086,405 $ 338,143 $ 3,424,548 Six Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Balance at beginning of period $ 3,295,214 $ 361,384 $ 3,656,598 $ 2,936,207 $ 358,801 $ 3,295,008 Initial negative allowance for expected recoveries - portfolio acquisitions (1) 545,409 79,777 625,186 515,595 42,389 557,984 Foreign currency translation adjustment (63,750) (1,902) (65,652) 43,216 8,082 51,298 Recoveries applied to negative allowance (2) (441,463) (79,477) (520,940) (385,283) (78,683) (463,966) Changes in expected recoveries (3) 115,311 9,683 124,994 (23,330) 7,554 (15,776) Balance at end of period $ 3,450,721 $ 369,465 $ 3,820,186 $ 3,086,405 $ 338,143 $ 3,424,548 (1) Initial negative allowance for expected recoveries - portfolio acquisitions Portfolio acquisitions for the three and six months ended June 30, 2024 and 2023 were as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Face value $ 2,402,148 $ 279,417 $ 2,681,565 $ 2,217,262 $ 91,940 $ 2,309,202 Noncredit discount (316,934) (23,186) (340,120) (240,532) (6,742) (247,274) Allowance for credit losses at acquisition (1,758,462) (203,614) (1,962,076) (1,668,456) (65,713) (1,734,169) Purchase price $ 326,752 $ 52,617 $ 379,369 $ 308,274 $ 19,485 $ 327,759 Six Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Face value $ 4,110,779 $ 393,633 $ 4,504,412 $ 3,725,226 $ 196,750 $ 3,921,976 Noncredit discount (548,319) (36,628) (584,947) (391,043) (14,784) (405,827) Allowance for credit losses at acquisition (3,017,051) (277,228) (3,294,279) (2,818,588) (139,577) (2,958,165) Purchase price $ 545,409 $ 79,777 $ 625,186 $ 515,595 $ 42,389 $ 557,984 The initial negative allowance recorded on portfolio acquisitions for the three and six months ended June 30, 2024 and 2023 was as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Allowance for credit losses at acquisition $ (1,758,462) $ (203,614) $ (1,962,076) $ (1,668,456) $ (65,713) $ (1,734,169) Writeoffs, net 1,758,462 203,614 1,962,076 1,668,456 65,713 1,734,169 Expected recoveries 326,752 52,617 379,369 308,274 19,485 327,759 Initial negative allowance for expected recoveries $ 326,752 $ 52,617 $ 379,369 $ 308,274 $ 19,485 $ 327,759 Six Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Allowance for credit losses at acquisition $ (3,017,051) $ (277,228) $ (3,294,279) $ (2,818,588) $ (139,577) $ (2,958,165) Writeoffs, net 3,017,051 277,228 3,294,279 2,818,588 139,577 2,958,165 Expected recoveries 545,409 79,777 625,186 515,595 42,389 557,984 Initial negative allowance for expected recoveries $ 545,409 $ 79,777 $ 625,186 $ 515,595 $ 42,389 $ 557,984 (2) Recoveries applied to negative allowance Recoveries applied to the negative allowance for the three and six months ended June 30, 2024 and 2023 were as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Recoveries (a) $ 423,659 $ 54,911 $ 478,570 $ 373,178 $ 49,370 $ 422,548 Less - amounts reclassified to portfolio income 197,412 11,878 209,290 174,281 10,009 184,290 Recoveries applied to negative allowance $ 226,247 $ 43,033 $ 269,280 $ 198,897 $ 39,361 $ 238,258 Six Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Recoveries (a) $ 829,972 $ 102,314 $ 932,286 $ 737,414 $ 99,084 $ 836,498 Less - amounts reclassified to portfolio income 388,509 22,837 411,346 352,131 20,401 372,532 Recoveries applied to negative allowance $ 441,463 $ 79,477 $ 520,940 $ 385,283 $ 78,683 $ 463,966 (a) Recoveries include cash collections, buybacks and other cash-based adjustments. (3) Changes in expected recoveries The Company develops its estimates of expected recoveries by applying discounted cash flow methodologies to its estimated remaining collections and recognizes income over the estimated life of the pool at the constant effective interest rate of the pool. For additional information about these methodologies, refer to Note 1 to the Consolidated Financial Statements in the 2023 Form 10-K. Changes in expected recoveries for the three months ended June 30, 2024 and 2023 were as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Recoveries received in excess of forecast $ 46,830 $ 7,430 $ 54,260 $ 21,536 $ 3,812 $ 25,348 Changes in expected future recoveries 18,917 143 19,060 (3,738) (474) (4,212) Changes in expected recoveries $ 65,747 $ 7,573 $ 73,320 $ 17,798 $ 3,338 $ 21,136 Changes in expected recoveries for the three months ended June 30, 2024 were $73.3 million, which included $54.3 million in recoveries received in excess of forecast (cash collections overperformance), due mainly to collections performance in the U.S., driven in large part by the Company's cash-generating initiatives, coupled with collections performance in Europe. Changes in expected future recoveries of $19.1 million mainly reflect the Company's assessment of certain pools in the U.S. and Europe, resulting in an increase to the expected cash flows based primarily on overperformance in recent periods. The increase in expected cash flows was driven in large part by forecast increases to the 2013 to 2019 U.S. Core pools, as well as increases to a number of pools in Europe. Changes in expected recoveries for the three months ended June 30, 2023 were a net positive $21.1 million. This included $25.3 million in recoveries received in excess of forecast (cash collections overperformance) and a $4.2 million negative adjustment to changes in expected future recoveries. The $25.3 million in recoveries received in excess of forecast was largely due to overperformance generated from larger than expected one-time payments in Europe and performance on new vintages in South America. Changes in expected recoveries for the six months ended June 30, 2024 and 2023 were as follows (amounts in thousands): Six Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Recoveries received in excess of forecast $ 80,748 $ 9,350 $ 90,098 $ 21,823 $ 7,363 $ 29,186 Changes in expected future recoveries 34,563 333 34,896 (45,153) 191 (44,962) Changes in expected recoveries $ 115,311 $ 9,683 $ 124,994 $ (23,330) $ 7,554 $ (15,776) Changes in expected recoveries for the six months ended June 30, 2024 were $125.0 million, which included $90.1 million in recoveries received in excess of forecast, due mainly to collections performance in the U.S., driven in large part by the Company's cash-generating initiatives, coupled with collections performance in Brazil and Europe. Changes in expected future recoveries of $34.9 million mainly reflect the Company's assessment of certain pools in the U.S. and Europe, resulting in an increase to the expected cash flows based primarily on overperformance in recent periods. The increase in expected cash flows was driven in large part by forecast increases to the 2013 to 2019 U.S. Core pools, as well as increases to a number of pools in Europe.

Investments

Investments	6 Months Ended
	Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Investments	Investments: Investments consisted of the following as of June 30, 2024 and December 31, 2023 (amounts in thousands): June 30, 2024 December 31, 2023 Debt securities Available-for-sale $ 47,918 $ 59,470 Equity securities Private equity funds 2,281 2,451 Equity method investment 9,420 10,483 Total investments $ 59,619 $ 72,404 Debt Securities Government securities: As of June 30, 2024, the Company's available-for-sale debt securities consisted of Swedish treasury securities maturing within one year. As of June 30, 2024 and December 31, 2023, the amortized cost and fair value of these investments were as follows (amounts in thousands): June 30, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Aggregate Fair Value Available-for-sale Government securities $ 47,741 $ 177 $ — $ 47,918 December 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Aggregate Fair Value Available-for-sale Government securities $ 59,404 $ 66 $ — $ 59,470 Equity Method Investment The Company ha s an 11.7% interest in RC

Goodwill

Goodwill	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill: The Company performs an annual review of goodwill as of October 1 of each year, or more frequently if indicators of impairment exist, with the most recent annual review performed as of October 1, 2023 . The Company performed a quarterly assessment by evaluating whether any triggering events had occurred as of June 30, 2024 , which included considering current market conditions, and determined that goodwill was not more-likely-than-not impaired. Changes in goodwill for the three and six months ended June 30, 2024 and 2023, were as follows (amounts in thousands): Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Balance as of beginning of period $ 411,846 $ 420,647 $ 431,564 $ 435,921 Foreign currency translation 3,800 (5,742) (15,918) (21,016) Balance as of end of period $ 415,646 $ 414,905 $ 415,646 $ 414,905

Borrowings

Borrowings	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Borrowings	Borrowings: Borrowings consisted of the following as of June 30, 2024 and December 31, 2023 (amounts in thousands): June 30, 2024 December 31, 2023 North American revolving credit facility (1) $ 219,305 $ 396,303 United Kingdom revolving credit facility (2) 495,665 502,847 European revolving credit facility (3) 533,653 538,565 North American term loan (4) 435,000 442,500 Credit facility borrowings 1,683,623 1,880,215 Senior Notes due 2025 (the "2025 Notes") 298,000 298,000 Senior Notes due 2028 (the "2028 Notes") 398,000 398,000 Senior Notes due 2029 (the "2029 Notes") 350,000 350,000 Senior Notes due 2030 (the "2030 Notes") 400,000 — Senior notes 1,446,000 1,046,000 Credit facility borrowings and senior notes 3,129,623 2,926,215 Debt discount and issuance costs (15,846) (11,945) Borrowings $ 3,113,777 $ 2,914,270 (1) Revolving credit facility under the Company's North American Revolving Credit and Term Loan (the "North American Credit Agreement"), which includes an aggregate principal amount of $1.5 billion (subject to compliance with a borrowing base and applicable debt covenants), consisting of (i) a fully-funded $435.0 million term loan (the "Term Loan"), (ii) a $1.0 billion domestic revolving credit facility, and (iii) a $75.0 million Canadian revolving credit facility, maturing on July 30, 2026. (2) Revolving credit facility under the Company's United Kingdom ("UK") Credit Agreement (the "UK Credit Agreement"), consisting of an $800.0 million revolving credit facility (subject to a borrowing base) a nd an accordion f eature for up to $200.0 million in additional commitments, subject to certain conditions, maturing on July 30, 2026 . (3) Revolving credit facility under the Company's European Credit Agreement (the "European Credit Agreement"), providing revolving borrowings for an aggregate amount of approximately €730.0 million (subject to the borrowing base and applicable debt covenants) and an accordion feature for up to €500.0 million, subject to certain conditions, maturing on November 23, 2027. As of June 30, 2024, after an increase in the limit during the prior quarter, interest bearing deposits in AK Nordic AB cannot exceed SEK2.2 billion . (4) Term Loan under t he North American Credit Agreement. During the three months ended June 30, 2024, the Company repaid $395.9 million aggregate principal amount of outstanding borrowings under the North American revolving credit facility with the net proceeds from the issuance of the 2030 Notes. For additional details about the North American Credit Agreement, the UK Credit Agreement, the European Credit Agreement and the Company's senior notes, r efer to Note 7 to the Consolidated Financial Statements in the 2023 Form 10-K and description of the 2030 Notes below. Th e Company determined that it was in compliance with the covenants contained in its financing arrangements as of June 30, 2024 . 2030 Notes On May 20, 2024, the Company completed the private offering of $400.0 million in aggregate principal amount of its 8.875% Senior Notes due January 31, 2030. The 2030 Notes were issued pursuant to an Indenture dated May 20, 2024 (the "2024 Indenture"), between the Company and Regions Bank, as trustee. The 2024 Indenture contains customary terms and covenants, including certain events of default after which the 2030 Notes may be due and payable immediately. The 2030 Notes are senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by all of the Company's existing and future domestic restricted subsidiaries that guarantee the North American Credit Agreement, subject to certain exceptions. Interest on the 2030 Notes is payable semi-annually, in arrears, on January 31 and July 31 of each year. Before June 1, 2026, the Company may redeem the 2030 Notes, in whole or in part, at a price equal to 100% of the aggregate principal amount of the 2030 Notes being redeemed, plus the applicable "make whole" premium. On or before June 1, 2026, the Company may redeem up to 40% of the aggregate principal amount of the 2030 Notes at a redemption price of 108.875% plus accrued and unpaid interest with the net cash proceeds of a public offering of common stock of the Company provided, that at least 60% in aggregate principal amount of the 2030 Notes remains outstanding immediately after the occurrence of such redemption and that such redemption will occur within 90 days of the date of the closing of such public offering. In ad dition, on or after June 1, 2026, the Company may redeem the 2030 Notes, in whole or in part, at a price equal to 104.438% of the aggregate principal amount of the 2030 Notes being redeemed. The applicable redemption price changes if redeemed during the 12 months beginning June 1 of each year to 102.219% for 2027 and then 100% for 2028 and thereafter. In the event of a change of control, each holder will have the right to require the Company to repurchase all or any part of such holder's 2030 Notes at an offer price equal to 101% of the aggregate principal amount plus accrued and unpaid interest. If the Company sells assets under certain circumstances and does not use the proceeds for specified purposes, the Company will be required to make an offer to repurchase the 2030 Notes at 100% of their principal amount plus accrued and unpaid interest.

Derivatives

Derivatives	6 Months Ended
	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	Derivatives: The Company periodically enters into derivative financial instruments; typically interest rate swaps and foreign currency contracts, to reduce its exposure to fluctuations in interest rates on variable-rate debt and foreign currency exchange rates. Derivative financial instruments are recognized at fair value in the Company's Consolidated Balance Sheets. For further discussion of the Company's use of, and accounting policies for, derivative instruments, refer to Notes 1 and 8 to the Consolidated Financial Statements in the 2023 Form 10-K. The following table summarizes the fair value of derivative financial instruments as of June 30, 2024 and December 31, 2023 (amounts in thousands): June 30, 2024 December 31, 2023 Balance Sheet Account Fair Value Balance Sheet Account Fair Value Derivatives designated as hedging instruments: Interest rate contracts Other assets $ 17,570 Other assets $ 21,770 Interest rate contracts Other liabilities 5,379 Other liabilities 11,627 Derivatives not designated as hedging instruments: Foreign currency contracts Other assets 890 Other assets 1,007 Foreign currency contracts Other liabilities 506 Other liabilities 8,776 Derivatives Designated as Hedging Instruments: Changes in the fair value of derivative contracts designated as cash flow hedging instruments are recognized in other comprehensive income ("OCI"). As of June 30, 2024 and December 31, 2023, the notional amount of interest rate contracts designated as cash flow hedging instruments w as $813.6 million and $872.3 million, respectively. Derivatives designated as cash flow hedging instruments remained highly effective as of June 30, 2024, and have remaining ter ms from six months to four years . As of June 30, 2024, t he Company estimat es that $11.5 million of net derivative gains included in OCI w ill be reclassified into earnings within the next 12 months. The following tables summarize the effects of derivatives designated as cash flow hedging instruments for the three and six months ended June 30, 2024 and 2023 (amounts in thousands): Gain recognized in OCI, net of tax Three Months Ended June 30, Six Months Ended June 30, Hedging instrument 2024 2023 2024 2023 Interest rate contracts $ 2,860 $ 10,771 $ 9,930 $ 10,142 Gain reclassified from OCI into income Three Months Ended June 30, Six Months Ended June 30, Income statement account 2024 2023 2024 2023 Interest expense, net $ 5,532 $ 6,670 $ 11,206 $ 12,168 During the three months ended June 30, 2024, the Company elected certain of the optional expedients in accordance with ASU 2021-01, "Reference Rate Reform (Topic 848): Overall" ("ASU 2021-01"), and ASU 2022-06, "Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848" (“ASU 2022-06”), to maintain cash flow hedge accounting for interest contracts with a combined notional amount of CAD 33.2 million. Derivatives Not Designated as Hedging Instruments: The Company enters into foreign currency contracts to economically hedge foreign currency remeasurement exposure related to certain balances denominated in currencies other than the functional currency of the Company or its international subsidiaries. Changes in fair value of derivative contracts not designated as hedging instruments are recognized in earnings. As of June 30, 2024 and December 31, 2023, the notional amount of foreign currency contracts w as $290.3 million and $368.5 million, respectively. The following table summarizes the effects of derivatives not designated as hedging instruments for the three and six months ended June 30, 2024 and 2023 (amounts in thousands): Gain/(loss) recognized in income Derivatives not designated as hedging instruments Three Months Ended June 30, Six Months Ended June 30, Income statement account 2024 2023 2024 2023 Foreign currency contracts Foreign exchange gain/(loss), net $ 726 $ (7,589) $ 826 $ (15,287) Foreign currency contracts Interest expense, net 117 631 309 1,153

Fair Value Measurements and Dis

Fair Value Measurements and Disclosures	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value	Fair Value: As defined by ASC Topic 820, "Fair Value Measurement and Disclosures" ("ASC 820"), fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 requires the consideration of different input levels in the determination of fair value, as follows: • Level 1: Quoted prices in active markets for identical assets and liabilities. • Level 2: Observable inputs other than Level 1 quoted prices, such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. • Level 3: Unobservable inputs that are supported by little or no market activity. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety. Financial Instruments Not Carried at Fair Value As of June 30, 2024 and December 31, 2023, the carrying amounts and estimated fair values of financial instruments not carried at fair value were as follows (amounts in thousands): June 30, 2024 December 31, 2023 Carrying Estimated Carrying Estimated Financial assets: Cash and cash equivalents $ 118,865 $ 118,865 $ 112,528 $ 112,528 Finance receivables, net 3,820,186 3,250,769 3,656,598 3,167,798 Financial liabilities: Interest-bearing deposits 114,991 114,991 115,589 115,589 Revolving lines of credit 1,248,623 1,248,623 1,437,715 1,437,715 Term Loan (1) 435,000 435,000 442,500 442,500 Senior notes (1) 1,446,000 1,397,557 1,046,000 964,907 (1) Carrying amounts and estimated fair values do not include debt issuance costs. The Company uses the following methods and assumptions to estimate the fair value of the above financial instruments: Cash equivalents: Carrying amount approximates fair value due to the short-term nature of the instruments and the observable quoted prices for identical assets in active markets. Accordingly, the Company uses Level 1 inputs. Finance receivables, net: The Company estimates the fair value of these receivables using proprietary pricing models that the Company utilizes to make portfolio acquisition decisions. Accordingly, the Company's fair value estimates use Level 3 inputs as there is little observable market data available and management is required to use significant judgment in its estimates. Interest-bearing deposits: Carrying amount approximates fair value due to the short-term nature of the deposits and the observable quoted prices for similar instruments in active markets. Accordingly, the Company uses Level 2 inputs for its fair value estimates. Revolving lines of credit: Carrying amount approximates fair value due to the short-term nature of the interest rate periods and the observable quoted prices for similar instruments in active markets. Accordingly, the Company uses Level 2 inputs for its fair value estimate. Term loan: Carrying amount approximates fair value due to the short-term nature of the interest rate periods and the observable quoted prices for similar instruments in active markets. Accordingly, the Company uses Level 2 inputs for its fair value estimate. Senior Notes: Fair value estimates for the Senior Notes incorporate quoted market prices obtained from secondary market broker quotes, which were derived from a variety of inputs, including client orders, information from their pricing vendors, modeling software and actual trading prices when they occur. Accordingly, the Company uses Level 2 inputs for its fair value estimates. Financial Instruments Carried at Fair Value As of June 30, 2024 and December 31, 2023, financial instruments measured at fair value on a recurring basis were as follows (amounts in thousands): Fair Value Measurements as of June 30, 2024 Level 1 Level 2 Level 3 Total Assets: Government securities $ 47,918 $ — $ — $ 47,918 Derivative contracts (recorded in Other assets) — 18,460 — 18,460 Liabilities: Derivative contracts (recorded in Other liabilities) — 5,885 — 5,885 Fair Value Measurements as of December 31, 2023 Level 1 Level 2 Level 3 Total Assets: Government securities $ 59,470 $ — $ — $ 59,470 Derivative contracts (recorded in Other assets) — 22,777 — 22,777 Liabilities: Derivative contracts (recorded in Other liabilities) — 20,403 — 20,403 The Company uses the following methods and assumptions to estimate the fair value of the above financial instruments: Government securities: Fair value of the Company's investments in government securities is estimated using quoted market prices. Accordingly, the Company uses Level 1 inputs. Derivative contracts: Fair value of derivative contracts is estimated using industry standard valuation models. These models project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves and other factors. Accordingly, the Company uses Level 2 inputs for its fair value estimates.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss: Reclassifications out of Accumulated other comprehensive loss for the three and six months ended June 30, 2024 and 2023, were as follows (amounts in thousands): Three Months Ended June 30, Six Months Ended June 30, Gain/(loss) on cash flow hedges Income Statement account 2024 2023 2024 2023 Interest rate swaps Interest expense, net $ 5,532 $ (6,670) $ 11,206 $ (12,168) Income tax effect of item above (1) Income tax expense/(benefit) (1,378) 1,618 (2,790) 2,914 Total gain/(loss) on cash flow hedges $ 4,154 $ (5,052) $ 8,416 $ (9,254) (1) Income tax effects are released from Accumulated other comprehensive loss contemporaneously with the related gross pretax amount. Changes in Accumulated other comprehensive loss by component, after tax, for the three and six months ended June 30, 2024 and 2023, were as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Debt Securities Cash Currency Accumulated Debt Securities Cash Currency Accumulated Available-for-sale Flow Hedges Translation Adjustments Other Comp. Loss (1) Available-for-sale Flow Hedges Translation Adjustments Other Comp. Loss (1) Balance as of beginning of period $ 111 $ 9,405 $ (382,534) $ (373,018) $ (109) $ 22,973 $ (379,594) $ (356,730) Other comprehensive gain/(loss) before reclassifications 65 2,861 (7,563) (4,637) (80) 10,771 3,091 13,782 Reclassifications, net — (4,154) — (4,154) — (5,052) — (5,052) Net current period other comprehensive gain/(loss) 65 (1,293) (7,563) (8,791) (80) 5,719 3,091 8,730 Balance as of end of period $ 176 $ 8,112 $ (390,097) $ (381,809) $ (189) $ 28,692 $ (376,503) $ (348,000) (1) Net of deferred taxes for unrealized (gains)/losses from cash flow hedges of $0.4 million and $(1.9) million for the three months ended June 30, 2024 and 2023, respectively. Six Months Ended June 30, 2024 2023 Debt Securities Cash Currency Accumulated Debt Securities Cash Currency Accumulated Available-for-sale Flow Hedges Translation Adjustments Other Comp. Loss (1) Available-for-sale Flow Hedges Translation Adjustments Other Comp. Loss (1) Balance at beginning of period $ 65 $ 6,597 $ (336,561) $ (329,899) $ (237) $ 27,804 $ (375,493) $ (347,926) Other comprehensive gain/(loss) before reclassifications 111 9,931 (53,536) (43,494) 48 10,142 (1,010) 9,180 Reclassifications, net — (8,416) — (8,416) — (9,254) — (9,254) Net current period other comprehensive gain/(loss) 111 1,515 (53,536) (51,910) 48 888 (1,010) (74) Balance at end of period $ 176 $ 8,112 $ (390,097) $ (381,809) $ (189) $ 28,692 $ (376,503) $ (348,000) (1) Net of deferred taxes for unrealized gains from cash flow hedges $(2.7) million and $(9.5) million for the six months ended June 30, 2024 and 2023, respectively.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings per Share: Basic earnings per share ("EPS") are computed by dividing net income available to common stockholders of PRA Group, Inc. by weighted average common shares outstanding. Diluted EPS are computed using the same components as basic EPS, with the denominator adjusted for nonvested share awards, if dilutive. Share-based awards that are contingent upon the attainment of performance goals are included in the computation of diluted EPS if the effect is dilutive. The dilutive effect of nonvested shares is computed using the treasury stock method, which assumes any proceeds that could be obtained upon the vesting of nonvested shares would be used to purchase common shares at the average market price for the period. The following tables provide a reconciliation between the computation of basic and diluted EPS f or the three and six months ended June 30, 2024 and 2023 (amounts in thousands, except per share amounts): Three Months Ended June 30, 2024 2023 Net Income Attributable to PRA Group, Inc. Weighted EPS Net Loss Attributable to PRA Group, Inc. Weighted EPS Basic EPS $ 21,516 39,364 $ 0.55 $ (3,804) 39,190 $ (0.10) Dilutive effect of nonvested share awards 182 (0.01) — — Diluted EPS $ 21,516 39,546 $ 0.54 $ (3,804) 39,190 $ (0.10) Six Months Ended June 30, 2024 2023 Net Loss Attributable to PRA Group, Inc. Weighted EPS Net Income Attributable to PRA Group, Inc. Weighted EPS Basic EPS $ 24,991 39,319 $ 0.64 $ (62,433) 39,111 $ (1.60) Dilutive effect of nonvested share awards 178 (0.01) — — Diluted EPS $ 24,991 39,497 $ 0.63 $ (62,433) 39,111 $ (1.60)

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	Commitments and Contingencies: Forward Flow Agreements: The Company enters into forward flow agreements for the purchase of nonperforming loans. These agreements typically have terms ranging from six to 12 months, or they can be open-ended, and establish purchase prices and specific criteria for the accounts to be purchased. Some of the agreements establish a volume reference for the contract term in the form of a target or maximum, however, very few agreements establish a minimum contractual obligation, and many of the contracts contain early termination provisions allowing either party to cancel the agreements in accordance with a specified notice period. The amounts purchased are also dependent on actual delivery by the sellers, and while purchases under these agreements comprise a significant portion of the Company's overall purchases, as of June 30, 2024, the minimum purchase obligation under these forward flow agreements was not significant. Litigation and Regulatory Matters: The Company and its subsidiaries are from time-to-time subject to a variety of legal and regulatory claims, inquiries and proceedings and regulatory matters, most of which are incidental to the ordinary course of its business. The Company initiates lawsuits against customers and is occasionally countersued by them in such actions. Also, customers, either individually, as members of a class action, or through a governmental entity on behalf of customers, may initiate litigation against the Company in which they allege that the Company has violated a law in the process of collecting on an account. From time-to-time, other types of lawsuits are brought against the Company. Additionally, the Company receives subpoenas and other requests or demands for information from regulators or governmental authorities who are investigating the Company's debt collection activities. The Company accrues for potential liability arising from legal proceedings and regulatory matters when it is probable that such liability has been incurred and the amount of the loss can be reasonably estimated. This determination is based upon currently available information for those proceedings in which the Company is involved, taking into account the Company's best estimate of such losses for those cases for which such estimates can be made. The Company's estimate involves significant judgment, given the varying stages of the proceedings (including the fact that many of them are currently in preliminary stages), the number of unresolved issues in many of the proceedings (including issues regarding class certification and the scope of many of the claims), and the related uncertainty of the potential outcomes of these proceedings. In making determinations of the likely outcome of pending litigation, the Company considers many factors, including, but not limited to, the nature of the claim, the Company's experience with similar types of claims, the jurisdiction in which the matter is filed, input from outside legal counsel, the likelihood of resolving the matter through alternative mechanisms, the matter's current status and the damages sought or demands made. Accordingly, the Company's estimate will change from time to time, and actual losses could exceed the current estimate. In certain legal proceedings, the Company may have recourse to insurance or third-party contractual indemnities to cover all or portions of its litigation expenses, judgments, or settlements. Loss estimates and accruals for potential liability related to legal proceedings are typically exclusive of potential recoveries, if any, under the Company's insurance policies or third-party indemnities.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net income	$ 21,516	$ (3,804)	$ 24,991	$ (62,433)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Martin Sjölund [Member]
Trading Arrangements, by Individual
Name	Martin Sjölund
Title	President of PRA Group Europe
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	May 31, 2024
Expiration Date	May 30, 2025
Arrangement Duration	364 days
Aggregate Available	14,433

Organization and Business (Poli

Organization and Business (Policies)	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of presentation : The Consolidated Financial Statements of the Company are prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). The accompanying interim financial statements have been prepared in accordance with the instructions for Quarterly Reports on Form 10-Q, and therefore, do not include all information and Notes to the Consolidated Financial Statements necessary for a complete presentation of financial position, results of operations, comprehensive income/(loss) and cash flows in conformity with GAAP. In the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair presentation of the Company's Consolidated Balance Sheets as of June 30, 2024, its Consolidated Income Statements and Statements of Comprehensive Income for the three and six months ended June 30, 2024 and 2023, and its Consolidated Statements of Changes in Equity and Statements of Cash Flows for the six months ended June 30, 2024 and 2023, have been included. The Consolidated Financial Statements include the accounts of PRA Group and other entities in which the Company has a controlling interest. All significant intercompany accounts and transactions have been eliminated.
New Accounting Pronouncements	Recently issued accounting standards not yet adopted: In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07"), which, among other updates, requires enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker, as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, and requires retrospective adoption. Early adoption is permitted. In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09"), which requires enhanced annual disclosures with respect to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, and may be adopted on a prospective or retrospective basis. Early adoption is permitted. The Company is currently evaluating both ASU 2023-07 and ASU 2023-09 to determine the impacts on its disclosures.

Finance Receivables, net (Table

Finance Receivables, net (Tables)	6 Months Ended
	Jun. 30, 2024
Receivables [Abstract]
Schedule of Finance Receivables, Net	Finance receivables, net consisted of the following as of June 30, 2024 and December 31, 2023 (amounts in thousands): June 30, 2024 December 31, 2023 Amortized cost $ — $ — Negative allowance for expected recoveries 3,820,186 3,656,598 Balance at end of period $ 3,820,186 $ 3,656,598
Schedule of Changes in Negative Allowance for Expected Recoveries	Changes in the negative allowance for expected recoveries by portfolio segment for the three and six months ended June 30, 2024 and 2023 were as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Balance at beginning of period $ 3,298,092 $ 352,103 $ 3,650,195 $ 2,935,850 $ 350,647 $ 3,286,497 Initial negative allowance for expected recoveries - portfolio acquisitions (1) 326,752 52,617 379,369 308,274 19,485 327,759 Foreign currency translation adjustment (13,623) 205 (13,418) 23,380 4,034 27,414 Recoveries applied to negative allowance (2) (226,247) (43,033) (269,280) (198,897) (39,361) (238,258) Changes in expected recoveries (3) 65,747 7,573 73,320 17,798 3,338 21,136 Balance at end of period $ 3,450,721 $ 369,465 $ 3,820,186 $ 3,086,405 $ 338,143 $ 3,424,548 Six Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Balance at beginning of period $ 3,295,214 $ 361,384 $ 3,656,598 $ 2,936,207 $ 358,801 $ 3,295,008 Initial negative allowance for expected recoveries - portfolio acquisitions (1) 545,409 79,777 625,186 515,595 42,389 557,984 Foreign currency translation adjustment (63,750) (1,902) (65,652) 43,216 8,082 51,298 Recoveries applied to negative allowance (2) (441,463) (79,477) (520,940) (385,283) (78,683) (463,966) Changes in expected recoveries (3) 115,311 9,683 124,994 (23,330) 7,554 (15,776) Balance at end of period $ 3,450,721 $ 369,465 $ 3,820,186 $ 3,086,405 $ 338,143 $ 3,424,548 (1) Initial negative allowance for expected recoveries - portfolio acquisitions Portfolio acquisitions for the three and six months ended June 30, 2024 and 2023 were as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Face value $ 2,402,148 $ 279,417 $ 2,681,565 $ 2,217,262 $ 91,940 $ 2,309,202 Noncredit discount (316,934) (23,186) (340,120) (240,532) (6,742) (247,274) Allowance for credit losses at acquisition (1,758,462) (203,614) (1,962,076) (1,668,456) (65,713) (1,734,169) Purchase price $ 326,752 $ 52,617 $ 379,369 $ 308,274 $ 19,485 $ 327,759 Six Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Face value $ 4,110,779 $ 393,633 $ 4,504,412 $ 3,725,226 $ 196,750 $ 3,921,976 Noncredit discount (548,319) (36,628) (584,947) (391,043) (14,784) (405,827) Allowance for credit losses at acquisition (3,017,051) (277,228) (3,294,279) (2,818,588) (139,577) (2,958,165) Purchase price $ 545,409 $ 79,777 $ 625,186 $ 515,595 $ 42,389 $ 557,984 The initial negative allowance recorded on portfolio acquisitions for the three and six months ended June 30, 2024 and 2023 was as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Allowance for credit losses at acquisition $ (1,758,462) $ (203,614) $ (1,962,076) $ (1,668,456) $ (65,713) $ (1,734,169) Writeoffs, net 1,758,462 203,614 1,962,076 1,668,456 65,713 1,734,169 Expected recoveries 326,752 52,617 379,369 308,274 19,485 327,759 Initial negative allowance for expected recoveries $ 326,752 $ 52,617 $ 379,369 $ 308,274 $ 19,485 $ 327,759 Six Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Allowance for credit losses at acquisition $ (3,017,051) $ (277,228) $ (3,294,279) $ (2,818,588) $ (139,577) $ (2,958,165) Writeoffs, net 3,017,051 277,228 3,294,279 2,818,588 139,577 2,958,165 Expected recoveries 545,409 79,777 625,186 515,595 42,389 557,984 Initial negative allowance for expected recoveries $ 545,409 $ 79,777 $ 625,186 $ 515,595 $ 42,389 $ 557,984 (2) Recoveries applied to negative allowance Recoveries applied to the negative allowance for the three and six months ended June 30, 2024 and 2023 were as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Recoveries (a) $ 423,659 $ 54,911 $ 478,570 $ 373,178 $ 49,370 $ 422,548 Less - amounts reclassified to portfolio income 197,412 11,878 209,290 174,281 10,009 184,290 Recoveries applied to negative allowance $ 226,247 $ 43,033 $ 269,280 $ 198,897 $ 39,361 $ 238,258 Six Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Recoveries (a) $ 829,972 $ 102,314 $ 932,286 $ 737,414 $ 99,084 $ 836,498 Less - amounts reclassified to portfolio income 388,509 22,837 411,346 352,131 20,401 372,532 Recoveries applied to negative allowance $ 441,463 $ 79,477 $ 520,940 $ 385,283 $ 78,683 $ 463,966 (a) Recoveries include cash collections, buybacks and other cash-based adjustments. (3) Changes in expected recoveries The Company develops its estimates of expected recoveries by applying discounted cash flow methodologies to its estimated remaining collections and recognizes income over the estimated life of the pool at the constant effective interest rate of the pool. For additional information about these methodologies, refer to Note 1 to the Consolidated Financial Statements in the 2023 Form 10-K. Changes in expected recoveries for the three months ended June 30, 2024 and 2023 were as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Recoveries received in excess of forecast $ 46,830 $ 7,430 $ 54,260 $ 21,536 $ 3,812 $ 25,348 Changes in expected future recoveries 18,917 143 19,060 (3,738) (474) (4,212) Changes in expected recoveries $ 65,747 $ 7,573 $ 73,320 $ 17,798 $ 3,338 $ 21,136 Changes in expected recoveries for the three months ended June 30, 2024 were $73.3 million, which included $54.3 million in recoveries received in excess of forecast (cash collections overperformance), due mainly to collections performance in the U.S., driven in large part by the Company's cash-generating initiatives, coupled with collections performance in Europe. Changes in expected future recoveries of $19.1 million mainly reflect the Company's assessment of certain pools in the U.S. and Europe, resulting in an increase to the expected cash flows based primarily on overperformance in recent periods. The increase in expected cash flows was driven in large part by forecast increases to the 2013 to 2019 U.S. Core pools, as well as increases to a number of pools in Europe. Changes in expected recoveries for the three months ended June 30, 2023 were a net positive $21.1 million. This included $25.3 million in recoveries received in excess of forecast (cash collections overperformance) and a $4.2 million negative adjustment to changes in expected future recoveries. The $25.3 million in recoveries received in excess of forecast was largely due to overperformance generated from larger than expected one-time payments in Europe and performance on new vintages in South America. Changes in expected recoveries for the six months ended June 30, 2024 and 2023 were as follows (amounts in thousands): Six Months Ended June 30, 2024 2023 Core Insolvency Total Core Insolvency Total Recoveries received in excess of forecast $ 80,748 $ 9,350 $ 90,098 $ 21,823 $ 7,363 $ 29,186 Changes in expected future recoveries 34,563 333 34,896 (45,153) 191 (44,962) Changes in expected recoveries $ 115,311 $ 9,683 $ 124,994 $ (23,330) $ 7,554 $ (15,776)

Investments (Tables)

Investments (Tables)	6 Months Ended
	Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Summary of Investments	Investments consisted of the following as of June 30, 2024 and December 31, 2023 (amounts in thousands): June 30, 2024 December 31, 2023 Debt securities Available-for-sale $ 47,918 $ 59,470 Equity securities Private equity funds 2,281 2,451 Equity method investment 9,420 10,483 Total investments $ 59,619 $ 72,404
Schedule of Amortized Cost and Estimated Fair Value in Debt Securities	June 30, 2024 and December 31, 2023, the amortized cost and fair value of these investments were as follows (amounts in thousands): June 30, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Aggregate Fair Value Available-for-sale Government securities $ 47,741 $ 177 $ — $ 47,918 December 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Aggregate Fair Value Available-for-sale Government securities $ 59,404 $ 66 $ — $ 59,470

Goodwill (Tables)

Goodwill (Tables)	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in Goodwill	hanges in goodwill for the three and six months ended June 30, 2024 and 2023, were as follows (amounts in thousands): Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Balance as of beginning of period $ 411,846 $ 420,647 $ 431,564 $ 435,921 Foreign currency translation 3,800 (5,742) (15,918) (21,016) Balance as of end of period $ 415,646 $ 414,905 $ 415,646 $ 414,905

Borrowings (Tables)

Borrowings (Tables)	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Schedule of Debt	Borrowings consisted of the following as of June 30, 2024 and December 31, 2023 (amounts in thousands): June 30, 2024 December 31, 2023 North American revolving credit facility (1) $ 219,305 $ 396,303 United Kingdom revolving credit facility (2) 495,665 502,847 European revolving credit facility (3) 533,653 538,565 North American term loan (4) 435,000 442,500 Credit facility borrowings 1,683,623 1,880,215 Senior Notes due 2025 (the "2025 Notes") 298,000 298,000 Senior Notes due 2028 (the "2028 Notes") 398,000 398,000 Senior Notes due 2029 (the "2029 Notes") 350,000 350,000 Senior Notes due 2030 (the "2030 Notes") 400,000 — Senior notes 1,446,000 1,046,000 Credit facility borrowings and senior notes 3,129,623 2,926,215 Debt discount and issuance costs (15,846) (11,945) Borrowings $ 3,113,777 $ 2,914,270 (1) Revolving credit facility under the Company's North American Revolving Credit and Term Loan (the "North American Credit Agreement"), which includes an aggregate principal amount of $1.5 billion (subject to compliance with a borrowing base and applicable debt covenants), consisting of (i) a fully-funded $435.0 million term loan (the "Term Loan"), (ii) a $1.0 billion domestic revolving credit facility, and (iii) a $75.0 million Canadian revolving credit facility, maturing on July 30, 2026. (2) Revolving credit facility under the Company's United Kingdom ("UK") Credit Agreement (the "UK Credit Agreement"), consisting of an $800.0 million revolving credit facility (subject to a borrowing base) a nd an accordion f eature for up to $200.0 million in additional commitments, subject to certain conditions, maturing on July 30, 2026 . (3) Revolving credit facility under the Company's European Credit Agreement (the "European Credit Agreement"), providing revolving borrowings for an aggregate amount of approximately €730.0 million (subject to the borrowing base and applicable debt covenants) and an accordion feature for up to €500.0 million, subject to certain conditions, maturing on November 23, 2027. As of June 30, 2024, after an increase in the limit during the prior quarter, interest bearing deposits in AK Nordic AB cannot exceed SEK2.2 billion . (4) Term Loan under t he North American Credit Agreement.

Derivatives (Tables)

Derivatives (Tables)	6 Months Ended
	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	The following table summarizes the fair value of derivative financial instruments as of June 30, 2024 and December 31, 2023 (amounts in thousands): June 30, 2024 December 31, 2023 Balance Sheet Account Fair Value Balance Sheet Account Fair Value Derivatives designated as hedging instruments: Interest rate contracts Other assets $ 17,570 Other assets $ 21,770 Interest rate contracts Other liabilities 5,379 Other liabilities 11,627 Derivatives not designated as hedging instruments: Foreign currency contracts Other assets 890 Other assets 1,007 Foreign currency contracts Other liabilities 506 Other liabilities 8,776
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location	The following tables summarize the effects of derivatives designated as cash flow hedging instruments for the three and six months ended June 30, 2024 and 2023 (amounts in thousands): Gain recognized in OCI, net of tax Three Months Ended June 30, Six Months Ended June 30, Hedging instrument 2024 2023 2024 2023 Interest rate contracts $ 2,860 $ 10,771 $ 9,930 $ 10,142 Gain reclassified from OCI into income Three Months Ended June 30, Six Months Ended June 30, Income statement account 2024 2023 2024 2023 Interest expense, net $ 5,532 $ 6,670 $ 11,206 $ 12,168
Schedule of derivative instruments not designated as hedging instruments	The following table summarizes the effects of derivatives not designated as hedging instruments for the three and six months ended June 30, 2024 and 2023 (amounts in thousands): Gain/(loss) recognized in income Derivatives not designated as hedging instruments Three Months Ended June 30, Six Months Ended June 30, Income statement account 2024 2023 2024 2023 Foreign currency contracts Foreign exchange gain/(loss), net $ 726 $ (7,589) $ 826 $ (15,287) Foreign currency contracts Interest expense, net 117 631 309 1,153

Fair Value Measurements and D_2

Fair Value Measurements and Disclosures (Tables)	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of financial instruments not required to be carried at fair value	carrying amounts and estimated fair values of financial instruments not carried at fair value were as follows (amounts in thousands): June 30, 2024 December 31, 2023 Carrying Estimated Carrying Estimated Financial assets: Cash and cash equivalents $ 118,865 $ 118,865 $ 112,528 $ 112,528 Finance receivables, net 3,820,186 3,250,769 3,656,598 3,167,798 Financial liabilities: Interest-bearing deposits 114,991 114,991 115,589 115,589 Revolving lines of credit 1,248,623 1,248,623 1,437,715 1,437,715 Term Loan (1) 435,000 435,000 442,500 442,500 Senior notes (1) 1,446,000 1,397,557 1,046,000 964,907 (1) Carrying amounts and estimated fair values do not include debt issuance costs. The Company uses the following methods and assumptions to estimate the fair value of the above financial instruments: Cash equivalents: Carrying amount approximates fair value due to the short-term nature of the instruments and the observable quoted prices for identical assets in active markets. Accordingly, the Company uses Level 1 inputs. Finance receivables, net: The Company estimates the fair value of these receivables using proprietary pricing models that the Company utilizes to make portfolio acquisition decisions. Accordingly, the Company's fair value estimates use Level 3 inputs as there is little observable market data available and management is required to use significant judgment in its estimates. Interest-bearing deposits: Carrying amount approximates fair value due to the short-term nature of the deposits and the observable quoted prices for similar instruments in active markets. Accordingly, the Company uses Level 2 inputs for its fair value estimates. Revolving lines of credit: Carrying amount approximates fair value due to the short-term nature of the interest rate periods and the observable quoted prices for similar instruments in active markets. Accordingly, the Company uses Level 2 inputs for its fair value estimate. Term loan: Carrying amount approximates fair value due to the short-term nature of the interest rate periods and the observable quoted prices for similar instruments in active markets. Accordingly, the Company uses Level 2 inputs for its fair value estimate. Senior Notes: Fair value estimates for the Senior Notes incorporate quoted market prices obtained from secondary market broker quotes, which were derived from a variety of inputs, including client orders, information from their pricing vendors, modeling software and actual trading prices when they occur. Accordingly, the Company uses Level 2 inputs for its fair value estimates.
Schedule of financial instruments required to be carried at fair value	at fair value on a recurring basis were as follows (amounts in thousands): Fair Value Measurements as of June 30, 2024 Level 1 Level 2 Level 3 Total Assets: Government securities $ 47,918 $ — $ — $ 47,918 Derivative contracts (recorded in Other assets) — 18,460 — 18,460 Liabilities: Derivative contracts (recorded in Other liabilities) — 5,885 — 5,885 Fair Value Measurements as of December 31, 2023 Level 1 Level 2 Level 3 Total Assets: Government securities $ 59,470 $ — $ — $ 59,470 Derivative contracts (recorded in Other assets) — 22,777 — 22,777 Liabilities: Derivative contracts (recorded in Other liabilities) — 20,403 — 20,403 The Company uses the following methods and assumptions to estimate the fair value of the above financial instruments: Government securities: Fair value of the Company's investments in government securities is estimated using quoted market prices. Accordingly, the Company uses Level 1 inputs. Derivative contracts: Fair value of derivative contracts is estimated using industry standard valuation models. These models project future cash flows and discount the future amounts to present value using market-based observable inputs, including interest rate curves and other factors. Accordingly, the Company uses Level 2 inputs for its fair value estimates.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
Reclassification out of Accumulated Other Comprehensive Income	Reclassifications out of Accumulated other comprehensive loss for the three and six months ended June 30, 2024 and 2023, were as follows (amounts in thousands): Three Months Ended June 30, Six Months Ended June 30, Gain/(loss) on cash flow hedges Income Statement account 2024 2023 2024 2023 Interest rate swaps Interest expense, net $ 5,532 $ (6,670) $ 11,206 $ (12,168) Income tax effect of item above (1) Income tax expense/(benefit) (1,378) 1,618 (2,790) 2,914 Total gain/(loss) on cash flow hedges $ 4,154 $ (5,052) $ 8,416 $ (9,254) (1) Income tax effects are released from Accumulated other comprehensive loss contemporaneously with the related gross pretax amount.
Schedule of Accumulated Other Comprehensive Income (Loss)	Changes in Accumulated other comprehensive loss by component, after tax, for the three and six months ended June 30, 2024 and 2023, were as follows (amounts in thousands): Three Months Ended June 30, 2024 2023 Debt Securities Cash Currency Accumulated Debt Securities Cash Currency Accumulated Available-for-sale Flow Hedges Translation Adjustments Other Comp. Loss (1) Available-for-sale Flow Hedges Translation Adjustments Other Comp. Loss (1) Balance as of beginning of period $ 111 $ 9,405 $ (382,534) $ (373,018) $ (109) $ 22,973 $ (379,594) $ (356,730) Other comprehensive gain/(loss) before reclassifications 65 2,861 (7,563) (4,637) (80) 10,771 3,091 13,782 Reclassifications, net — (4,154) — (4,154) — (5,052) — (5,052) Net current period other comprehensive gain/(loss) 65 (1,293) (7,563) (8,791) (80) 5,719 3,091 8,730 Balance as of end of period $ 176 $ 8,112 $ (390,097) $ (381,809) $ (189) $ 28,692 $ (376,503) $ (348,000) (1) Net of deferred taxes for unrealized (gains)/losses from cash flow hedges of $0.4 million and $(1.9) million for the three months ended June 30, 2024 and 2023, respectively. Six Months Ended June 30, 2024 2023 Debt Securities Cash Currency Accumulated Debt Securities Cash Currency Accumulated Available-for-sale Flow Hedges Translation Adjustments Other Comp. Loss (1) Available-for-sale Flow Hedges Translation Adjustments Other Comp. Loss (1) Balance at beginning of period $ 65 $ 6,597 $ (336,561) $ (329,899) $ (237) $ 27,804 $ (375,493) $ (347,926) Other comprehensive gain/(loss) before reclassifications 111 9,931 (53,536) (43,494) 48 10,142 (1,010) 9,180 Reclassifications, net — (8,416) — (8,416) — (9,254) — (9,254) Net current period other comprehensive gain/(loss) 111 1,515 (53,536) (51,910) 48 888 (1,010) (74) Balance at end of period $ 176 $ 8,112 $ (390,097) $ (381,809) $ (189) $ 28,692 $ (376,503) $ (348,000) (1) Net of deferred taxes for unrealized gains from cash flow hedges $(2.7) million and $(9.5) million for the six months ended June 30, 2024 and 2023, respectively.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Reconciliation Between the Computation of Basic and Diluted EPS	The following tables provide a reconciliation between the computation of basic and diluted EPS f or the three and six months ended June 30, 2024 and 2023 (amounts in thousands, except per share amounts): Three Months Ended June 30, 2024 2023 Net Income Attributable to PRA Group, Inc. Weighted EPS Net Loss Attributable to PRA Group, Inc. Weighted EPS Basic EPS $ 21,516 39,364 $ 0.55 $ (3,804) 39,190 $ (0.10) Dilutive effect of nonvested share awards 182 (0.01) — — Diluted EPS $ 21,516 39,546 $ 0.54 $ (3,804) 39,190 $ (0.10) Six Months Ended June 30, 2024 2023 Net Loss Attributable to PRA Group, Inc. Weighted EPS Net Income Attributable to PRA Group, Inc. Weighted EPS Basic EPS $ 24,991 39,319 $ 0.64 $ (62,433) 39,111 $ (1.60) Dilutive effect of nonvested share awards 178 (0.01) — — Diluted EPS $ 24,991 39,497 $ 0.63 $ (62,433) 39,111 $ (1.60)

Finance Receivables, net (Rollf

Finance Receivables, net (Rollforward) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Receivables [Abstract]
Amortized cost	$ 0		$ 0			$ 0
Negative allowance for expected recoveries	3,820,186		3,820,186			3,656,598
Balance at end of period	3,820,186	$ 3,424,548	3,820,186	$ 3,424,548	$ 3,650,195	3,656,598	$ 3,286,497	$ 3,295,008
Financing Receivable, Allowance for Credit Losses [Line Items]
Balance at end of period	3,820,186	3,424,548	3,820,186	3,424,548	3,650,195	3,656,598	3,286,497	3,295,008
Initial negative allowance for expected recoveries - acquisitions	379,369	327,759	625,186	557,984
Foreign currency translation adjustment	(13,418)	27,414	(65,652)	51,298
Financing Receivable, Allowance for Credit Loss, Recovery	(269,280)	(238,258)	(520,940)	(463,966)
Changes in estimated recoveries	73,320	21,136	124,994	(15,776)
Core
Receivables [Abstract]
Balance at end of period	3,450,721	3,086,405	3,450,721	3,086,405	3,298,092	3,295,214	2,935,850	2,936,207
Financing Receivable, Allowance for Credit Losses [Line Items]
Balance at end of period	3,450,721	3,086,405	3,450,721	3,086,405	3,298,092	3,295,214	2,935,850	2,936,207
Initial negative allowance for expected recoveries - acquisitions	326,752	308,274	545,409	515,595
Foreign currency translation adjustment	(13,623)	23,380	(63,750)	43,216
Financing Receivable, Allowance for Credit Loss, Recovery	(226,247)	(198,897)	(441,463)	(385,283)
Changes in estimated recoveries	65,747	17,798	115,311	(23,330)
Insolvency
Receivables [Abstract]
Balance at end of period	369,465	338,143	369,465	338,143	352,103	361,384	350,647	358,801
Financing Receivable, Allowance for Credit Losses [Line Items]
Balance at end of period	369,465	338,143	369,465	338,143	$ 352,103	$ 361,384	$ 350,647	$ 358,801
Initial negative allowance for expected recoveries - acquisitions	52,617	19,485	79,777	42,389
Foreign currency translation adjustment	205	4,034	(1,902)	8,082
Financing Receivable, Allowance for Credit Loss, Recovery	(43,033)	(39,361)	(79,477)	(78,683)
Changes in estimated recoveries	$ 7,573	$ 3,338	$ 9,683	$ 7,554

Finance Receivables, net Financ

Finance Receivables, net Finance Receivables, net (Allowance for Expected Recoveries) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Balance at beginning of period			$ 3,656,598
Initial negative allowance for expected recoveries - acquisitions	$ 379,369	$ 327,759	625,186	$ 557,984
Foreign currency translation adjustment	(13,418)	27,414	(65,652)	51,298
Recoveries applied to negative allowance	269,280	238,258	520,940	463,966
Changes in estimated recoveries	73,320	21,136	124,994	(15,776)
Balance at end of period	3,820,186		3,820,186
Balance at end of period	3,820,186	3,424,548	3,820,186	3,424,548	$ 3,650,195	$ 3,656,598	$ 3,286,497	$ 3,295,008
Core
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Initial negative allowance for expected recoveries - acquisitions	326,752	308,274	545,409	515,595
Foreign currency translation adjustment	(13,623)	23,380	(63,750)	43,216
Recoveries applied to negative allowance	226,247	198,897	441,463	385,283
Changes in estimated recoveries	65,747	17,798	115,311	(23,330)
Balance at end of period	3,450,721	3,086,405	3,450,721	3,086,405	3,298,092	3,295,214	2,935,850	2,936,207
Insolvency
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Initial negative allowance for expected recoveries - acquisitions	52,617	19,485	79,777	42,389
Foreign currency translation adjustment	205	4,034	(1,902)	8,082
Recoveries applied to negative allowance	43,033	39,361	79,477	78,683
Changes in estimated recoveries	7,573	3,338	9,683	7,554
Balance at end of period	$ 369,465	$ 338,143	$ 369,465	$ 338,143	$ 352,103	$ 361,384	$ 350,647	$ 358,801

Finance Receivables, net (Portf

Finance Receivables, net (Portfolio Acquisitions) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Face value	$ 2,681,565	$ 2,309,202	$ 4,504,412	$ 3,921,976
Noncredit discount	(340,120)	(247,274)	(584,947)	(405,827)
Allowance for credit losses at acquisition	(1,962,076)	(1,734,169)	(3,294,279)	(2,958,165)
Purchase price	379,369	327,759	625,186	557,984
Core
Accounts, Notes, Loans and Financing Receivable [Line Items]
Face value	2,402,148	2,217,262	4,110,779	3,725,226
Noncredit discount	(316,934)	(240,532)	(548,319)	(391,043)
Allowance for credit losses at acquisition	(1,758,462)	(1,668,456)	(3,017,051)	(2,818,588)
Purchase price	326,752	308,274	545,409	515,595
Insolvency
Accounts, Notes, Loans and Financing Receivable [Line Items]
Face value	279,417	91,940	393,633	196,750
Noncredit discount	(23,186)	(6,742)	(36,628)	(14,784)
Allowance for credit losses at acquisition	(203,614)	(65,713)	(277,228)	(139,577)
Purchase price	$ 52,617	$ 19,485	$ 79,777	$ 42,389

Finance Receivables, net Fina_2

Finance Receivables, net Finance Receivables, net (Initial Negative Allowance for Recoveries) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for credit losses at acquisition	$ (1,962,076)	$ (1,734,169)	$ (3,294,279)	$ (2,958,165)
Writeoffs, net	1,962,076	1,734,169	3,294,279	2,958,165
Expected recoveries	379,369	327,759	625,186	557,984
Purchase price	379,369	327,759	625,186	557,984
Amortized cost	0		0			$ 0
Negative allowance for expected recoveries	3,820,186		3,820,186			3,656,598
Balance at end of period	3,820,186	3,424,548	3,820,186	3,424,548	$ 3,650,195	3,656,598	$ 3,286,497	$ 3,295,008
Core
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for credit losses at acquisition	(1,758,462)	(1,668,456)	(3,017,051)	(2,818,588)
Writeoffs, net	1,758,462	1,668,456	3,017,051	2,818,588
Expected recoveries	326,752	308,274	545,409	515,595
Purchase price	326,752	308,274	545,409	515,595
Balance at end of period	3,450,721	3,086,405	3,450,721	3,086,405	3,298,092	3,295,214	2,935,850	2,936,207
Insolvency
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for credit losses at acquisition	(203,614)	(65,713)	(277,228)	(139,577)
Writeoffs, net	203,614	65,713	277,228	139,577
Expected recoveries	52,617	19,485	79,777	42,389
Purchase price	52,617	19,485	79,777	42,389
Balance at end of period	$ 369,465	$ 338,143	$ 369,465	$ 338,143	$ 352,103	$ 361,384	$ 350,647	$ 358,801

Finance Receivables, net Fina_3

Finance Receivables, net Finance Receivables, net (Recoveries) (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Financing Receivable, Allowance for Credit Losses [Line Items]
Recoveries	$ 478,570		$ 422,548		$ 932,286	$ 836,498
Less - amounts reclassified to portfolio income	209,290		184,290		411,346	372,532
Recoveries applied to negative allowance	269,280		238,258		520,940	463,966
Amortized cost	0				0		$ 0
Balance at end of period	3,820,186	$ 3,650,195	3,424,548	$ 3,286,497	3,820,186	3,424,548	3,656,598	$ 3,295,008
Initial negative allowance for expected recoveries - acquisitions	379,369		327,759		625,186	557,984
Foreign currency translation adjustment	(13,418)		27,414		(65,652)	51,298
Changes in estimated recoveries	73,320		21,136		124,994	(15,776)
Debt Securities, Available-for-Sale	47,918				47,918		59,470
Equity Method Investments	9,420				9,420		10,483
Additional Paid-in Capital
Financing Receivable, Allowance for Credit Losses [Line Items]
Vesting of restricted stock	(1)	(1)	0	(2)
Common Stock
Financing Receivable, Allowance for Credit Losses [Line Items]
Vesting of restricted stock	1	1	0	2
Government Bonds and Fixed Income Funds [Member]
Financing Receivable, Allowance for Credit Losses [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost	47,741				47,741		59,404
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	177				177		66
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	0				0		0
Debt Securities, Available-for-Sale	47,918				47,918		59,470
Core
Financing Receivable, Allowance for Credit Losses [Line Items]
Recoveries	423,659		373,178		829,972	737,414
Less - amounts reclassified to portfolio income	197,412		174,281		388,509	352,131
Recoveries applied to negative allowance	226,247		198,897		441,463	385,283
Balance at end of period	3,450,721	3,298,092	3,086,405	2,935,850	3,450,721	3,086,405	3,295,214	2,936,207
Initial negative allowance for expected recoveries - acquisitions	326,752		308,274		545,409	515,595
Foreign currency translation adjustment	(13,623)		23,380		(63,750)	43,216
Changes in estimated recoveries	65,747		17,798		115,311	(23,330)
Insolvency
Financing Receivable, Allowance for Credit Losses [Line Items]
Recoveries	54,911		49,370		102,314	99,084
Less - amounts reclassified to portfolio income	11,878		10,009		22,837	20,401
Recoveries applied to negative allowance	43,033		39,361		79,477	78,683
Balance at end of period	369,465	$ 352,103	338,143	$ 350,647	369,465	338,143	$ 361,384	$ 358,801
Initial negative allowance for expected recoveries - acquisitions	52,617		19,485		79,777	42,389
Foreign currency translation adjustment	205		4,034		(1,902)	8,082
Changes in estimated recoveries	$ 7,573		$ 3,338		$ 9,683	$ 7,554

Finance Receivables, net (Chang

Finance Receivables, net (Changes in Estimated Future Recoveries) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Financing Receivable, Allowance for Credit Losses [Line Items]
Changes in expected future recoveries	$ 19,060	$ (4,212)	$ 34,896	$ (44,962)
Recoveries received in excess of forecast	54,260	25,348	90,098	29,186
Financing Receivable, Allowance For Credit Loss, Changes In Estimated Recoveries	73,320	21,136	124,994	(15,776)
Recoveries	478,570	422,548	932,286	836,498
Less - amounts reclassified to portfolio income	209,290	184,290	411,346	372,532
Recoveries applied to negative allowance	269,280	238,258	520,940	463,966
Core
Financing Receivable, Allowance for Credit Losses [Line Items]
Changes in expected future recoveries	18,917	(3,738)	34,563	(45,153)
Recoveries received in excess of forecast	46,830	21,536	80,748	21,823
Financing Receivable, Allowance For Credit Loss, Changes In Estimated Recoveries	65,747	17,798	115,311	(23,330)
Recoveries	423,659	373,178	829,972	737,414
Less - amounts reclassified to portfolio income	197,412	174,281	388,509	352,131
Recoveries applied to negative allowance	226,247	198,897	441,463	385,283
Insolvency
Financing Receivable, Allowance for Credit Losses [Line Items]
Changes in expected future recoveries	143	(474)	333	191
Recoveries received in excess of forecast	7,430	3,812	9,350	7,363
Financing Receivable, Allowance For Credit Loss, Changes In Estimated Recoveries	7,573	3,338	9,683	7,554
Recoveries	54,911	49,370	102,314	99,084
Less - amounts reclassified to portfolio income	11,878	10,009	22,837	20,401
Recoveries applied to negative allowance	$ 43,033	$ 39,361	$ 79,477	$ 78,683

Finance Receivables, net (Narra

Finance Receivables, net (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Receivables [Abstract]
Changes in estimated recoveries	$ 73,320	$ 21,136	$ 124,994	$ (15,776)
Recoveries received in excess of forecast	54,260	25,348	90,098	29,186
Changes in expected future recoveries	$ 19,060	$ (4,212)	$ 34,896	$ (44,962)

Investments - Summary of Invest

Investments - Summary of Investments (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Debt Securities [Abstract]
Debt Securities, Available-for-Sale	$ 47,918	$ 59,470
Equity Securities [Abstract]
Equity Method Investments	9,420	10,483
Investments	59,619	72,404
Private equity funds
Equity Securities [Abstract]
Equity Securities, FV-NI, Current	$ 2,281	$ 2,451

Investments - Amortized Costs (

Investments - Amortized Costs (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Available-for-sale
Debt Securities, Available-for-Sale	$ 47,918	$ 59,470
Government Bonds and Fixed Income Funds
Available-for-sale
Debt Securities, Available-for-Sale, Amortized Cost	47,741	59,404
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	177	66
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	0	0
Debt Securities, Available-for-Sale	$ 47,918	$ 59,470

Investments - Narrative (Detail

Investments - Narrative (Details)	Jun. 30, 2024
RCB Investimentos S.A. (RCB) | RCB Investimentos S.A.
Debt and Equity Securities, FV-NI [Line Items]
Ownership percentage	11.70%

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 411,846	$ 420,647	$ 431,564	$ 435,921
Goodwill, Foreign Currency Translation Gain (Loss)	3,800	(5,742)	(15,918)	(21,016)
Goodwill, Ending Balance	$ 415,646	$ 414,905	$ 415,646	$ 414,905

Borrowings - Components of Borr

Borrowings - Components of Borrowings (Details) € in Millions, kr in Billions		3 Months Ended
	May 20, 2024 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2024 EUR (€)	Jun. 30, 2024 SEK (kr)	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Debt outstanding		$ 3,129,623,000			$ 2,926,215,000
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net		(15,846,000)			(11,945,000)
Debt, Long-Term and Short-Term, Combined Amount		3,113,777,000			2,914,270,000
North American Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		1,500,000,000
Repayments of Lines of Credit		395,900,000
Loans Payable | North American Credit Agreement
Debt Instrument [Line Items]
Debt outstanding		435,000,000			442,500,000
Line of Credit and Loans Payable
Debt Instrument [Line Items]
Debt outstanding		1,683,623,000			1,880,215,000
Senior Notes
Debt Instrument [Line Items]
Principal amount		1,446,000,000			1,046,000,000
Senior Notes | 2029 Notes
Debt Instrument [Line Items]
Principal amount		350,000,000			350,000,000
Senior Notes | 2028 Notes
Debt Instrument [Line Items]
Principal amount		398,000,000			398,000,000
Senior Notes | 2025 Notes
Debt Instrument [Line Items]
Principal amount		298,000,000			298,000,000
Senior Notes | 2030 Notes
Debt Instrument [Line Items]
Principal amount	$ 400,000,000	400,000,000			0
Stated percentage	8.875%
Senior Notes | 2030 Notes | Change Of Control Event
Debt Instrument [Line Items]
Redemption price of original principal amount	101%
Senior Notes | 2030 Notes | Certain Asset Sale Events
Debt Instrument [Line Items]
Redemption price of original principal amount	100%
Senior Notes | 2030 Notes | On or Before June 1, 2026
Debt Instrument [Line Items]
Redemption price, percentage of aggregate principal amount	100%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed - Offering of Common Stock	40%
Redemption price of original principal amount	108.875%
Redemption price, minimum percentage of principal amount outstanding	60%
Senior Notes | 2030 Notes | On or After June 1, 2026
Debt Instrument [Line Items]
Redemption price of original principal amount	104.438%
Senior Notes | 2030 Notes | June 1, 2027 to May 31, 2028
Debt Instrument [Line Items]
Redemption price of original principal amount	102.219%
Senior Notes | 2030 Notes | June 1, 2028 and Thereafter
Debt Instrument [Line Items]
Redemption price of original principal amount	100%
Americas Revolving Credit Facility | Line of Credit
Debt Instrument [Line Items]
Debt outstanding		219,305,000			396,303,000
UK revolving credit facility | Line of Credit | UK Credit Agreement
Debt Instrument [Line Items]
Debt outstanding		495,665,000			502,847,000
Long term line of debt, accordion feature		200,000,000
Line of Credit Facility, Maximum Borrowing Capacity		800,000,000
European revolving credit facility | European Revolving Credit Facility | Maximum
Debt Instrument [Line Items]
Debt Instrument, covenant, interest bearing deposits, maximum | kr				kr 2.2
European revolving credit facility | Line of Credit | European Revolving Credit Facility
Debt Instrument [Line Items]
Debt outstanding		533,653,000			$ 538,565,000
Long term line of debt, accordion feature | €			€ 500
Line of Credit Facility, Maximum Borrowing Capacity | €			€ 730
Revolving Credit Facility | North American Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		1,000,000,000
Canadian Revolving Credit Facility | North American Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 75,000,000

Derivatives - Schedule of Deriv

Derivatives - Schedule of Derivatives by Balance Sheet Location (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Derivatives, Fair Value [Line Items]
Derivative Liability	$ 5,885	$ 20,403
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets	Other Assets
Derivative Asset	$ 18,460	$ 22,777
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Current	Other Liabilities, Current
Interest expense, net | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative Liability	$ 5,379	$ 11,627
Derivative Asset	17,570	21,770
Foreign currency contracts | Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative Liability	506	8,776
Derivative Asset	$ 890	$ 1,007

Derivatives - Narrative (Detail

Derivatives - Narrative (Details) $ in Millions, $ in Millions	3 Months Ended
	Jun. 30, 2024 CAD ($)	Jun. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
Derivative [Line Items]
Hedging Contracts, ASU 2021-01 Optional Expedients, Notional Value	$ 33.2
Designated as Hedging Instrument | Interest expense, net
Derivative [Line Items]
Derivative, Notional Amount1		$ 813.6	$ 872.3
Net derivative gain (loss) included in OCI to be reclassified next 12 months		11.5
Not Designated as Hedging Instrument | Foreign currency contracts
Derivative [Line Items]
Derivative, Notional Amount1		$ 290.3	$ 368.5
Maximum
Derivative [Line Items]
Derivative, Term of Contract	4 years
Minimum
Derivative [Line Items]
Derivative, Term of Contract	6 months

Derivatives - Schedule of Effec

Derivatives - Schedule of Effects of Derivatives Designated as Cash Flow Hedging Instruments (Details) - Interest expense, net - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Gain recognized in OCI, net of tax	$ 2,860	$ 10,771	$ 9,930	$ 10,142
Interest expense, net
Derivative Instruments, Gain (Loss) [Line Items]
Gain reclassified from OCI into income	$ 5,532	$ 6,670	$ 11,206	$ 12,168

Derivatives - Schedule of Eff_2

Derivatives - Schedule of Effects of Derivatives Not Designated as Hedging Instruments (Details) - Foreign currency contracts - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Foreign Currency Gain (Loss) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain/(loss) recognized in income	$ 726	$ (7,589)	$ 826	$ (15,287)
Interest expense, net
Derivative Instruments, Gain (Loss) [Line Items]
Gain/(loss) recognized in income	$ 117	$ 631	$ 309	$ 1,153

Fair Value Measurements And D_3

Fair Value Measurements And Disclosures - Financial Instruments Not Required to be Carried at Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023	Jun. 30, 2023
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and cash equivalents, carrying amount	$ 118,865	$ 112,528	$ 111,375
Financing Receivable, after Allowance for Credit Loss, Current	3,820,186	3,656,598
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Interest-bearing deposits, carrying value	114,991	115,589
Restricted Cash and Cash Equivalents	1,052		$ 13,290
Reported Value Measurement [Member]
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and cash equivalents, carrying amount	118,865	112,528
Financing Receivable, after Allowance for Credit Loss, Current	3,820,186	3,656,598
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Interest-bearing deposits, carrying value	114,991	115,589
Outstanding borrowings under credit facility	1,248,623	1,437,715
Term loans, carrying amount	435,000	442,500
Senior Notes, carrying amount	1,446,000	1,046,000
Estimate of Fair Value Measurement [Member]
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]
Cash and cash equivalents, estimated fair value	118,865	112,528
Finance receivables, net, estimated fair value	3,250,769	3,167,798
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]
Interest-bearing deposits, fair value	114,991	115,589
Revolving lines of credit, estimated fair value	1,248,623	1,437,715
Term loans, estimated fair value	435,000	442,500
Debt Instrument, Fair Value Disclosure	$ 1,397,557	$ 964,907

Fair Value Fair Value Measureme

Fair Value Fair Value Measurements and Disclosures - Financial Instruments Required to be Carried at Fair Value (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Assets, Fair Value Disclosure [Abstract]
Debt Securities, Available-for-Sale	$ 47,918	$ 59,470
Derivative Asset	18,460	22,777
Financial Liabilities Fair Value Disclosure [Abstract]
Derivative Liability	5,885	20,403
Fair Value, Inputs, Level 1 [Member]
Assets, Fair Value Disclosure [Abstract]
Derivative Asset	0	0
Financial Liabilities Fair Value Disclosure [Abstract]
Derivative Liability	0	0
Fair Value, Inputs, Level 2 [Member]
Assets, Fair Value Disclosure [Abstract]
Derivative Asset	18,460	22,777
Financial Liabilities Fair Value Disclosure [Abstract]
Derivative Liability	5,885	20,403
Fair Value, Inputs, Level 3 [Member]
Assets, Fair Value Disclosure [Abstract]
Derivative Asset	0	0
Financial Liabilities Fair Value Disclosure [Abstract]
Derivative Liability	0	0
Government Bonds [Member]
Assets, Fair Value Disclosure [Abstract]
Debt Securities, Available-for-Sale	47,918	59,470
Government Bonds [Member] | Fair Value, Inputs, Level 1 [Member]
Assets, Fair Value Disclosure [Abstract]
Debt Securities, Available-for-Sale	47,918	59,470
Government Bonds [Member] | Fair Value, Inputs, Level 2 [Member]
Assets, Fair Value Disclosure [Abstract]
Debt Securities, Available-for-Sale	0	0
Government Bonds [Member] | Fair Value, Inputs, Level 3 [Member]
Assets, Fair Value Disclosure [Abstract]
Debt Securities, Available-for-Sale	$ 0	$ 0

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss - Reclassifications out of AOCI (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Income tax expense/(benefit)	$ 8,702	$ 1,578	$ 11,088	$ (17,105)
Net income	25,114	1,160	36,867	(52,743)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,203,278	1,239,674	1,203,278	1,239,674	$ 1,196,318	$ 1,239,376	$ 1,224,709	$ 1,286,750
Other comprehensive (loss)/income before reclassifications, net	(4,637)	13,782	(43,494)	9,180
Reclassifications	(4,154)	(5,052)	(8,416)	(9,254)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(8,791)	8,730	(51,910)	(74)
Interest Income (Expense), Nonoperating	(55,353)	(43,022)	(107,631)	(81,305)
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	8,112	28,692	8,112	28,692	9,405	6,597	22,973	27,804
Other comprehensive (loss)/income before reclassifications, net	2,861	10,771	9,931	10,142
Reclassifications	(4,154)	(5,052)	(8,416)	(9,254)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(1,293)	5,719	1,515	888
Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	(390,097)	(376,503)	(390,097)	(376,503)	(382,534)	(336,561)	(379,594)	(375,493)
Other comprehensive (loss)/income before reclassifications, net	(7,563)	3,091	(53,536)	(1,010)
Reclassifications	0	0	0	0
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(7,563)	3,091	(53,536)	(1,010)
Debt Securities Available-for-sale
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	176	(189)	176	(189)	111	65	(109)	(237)
Other comprehensive (loss)/income before reclassifications, net	65	(80)	111	48
Reclassifications	0	0	0	0
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	65	(80)	111	48
Accumulated Other Comprehensive (Loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	(381,809)	(348,000)	(381,809)	(348,000)	$ (373,018)	$ (329,899)	$ (356,730)	$ (347,926)
Reclassification out of Accumulated Other Comprehensive Income | Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Income tax expense/(benefit)	(1,378)	1,618	(2,790)	2,914
Net income	4,154	(5,052)	8,416	(9,254)
Interest Income (Expense), Nonoperating	$ 5,532	$ (6,670)	$ 11,206	$ (12,168)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss - AOCI by Component (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 1,196,318	$ 1,224,709	$ 1,239,376	$ 1,286,750
Other comprehensive (loss)/income before reclassifications, net	(4,637)	13,782	(43,494)	9,180
Reclassifications	(4,154)	(5,052)	(8,416)	(9,254)
Other comprehensive loss attributable to PRA Group, Inc.	(8,791)	8,730	(51,910)	(74)
Ending balance	1,203,278	1,239,674	1,203,278	1,239,674
Deferred taxes for unrealized losses from cash flow hedges	400	(1,900)	(2,700)	(9,500)
Debt Securities Available-for-sale
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	111	(109)	65	(237)
Other comprehensive (loss)/income before reclassifications, net	65	(80)	111	48
Reclassifications	0	0	0	0
Other comprehensive loss attributable to PRA Group, Inc.	65	(80)	111	48
Ending balance	176	(189)	176	(189)
Cash Flow Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	9,405	22,973	6,597	27,804
Other comprehensive (loss)/income before reclassifications, net	2,861	10,771	9,931	10,142
Reclassifications	(4,154)	(5,052)	(8,416)	(9,254)
Other comprehensive loss attributable to PRA Group, Inc.	(1,293)	5,719	1,515	888
Ending balance	8,112	28,692	8,112	28,692
Currency Translation Adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(382,534)	(379,594)	(336,561)	(375,493)
Other comprehensive (loss)/income before reclassifications, net	(7,563)	3,091	(53,536)	(1,010)
Reclassifications	0	0	0	0
Other comprehensive loss attributable to PRA Group, Inc.	(7,563)	3,091	(53,536)	(1,010)
Ending balance	(390,097)	(376,503)	(390,097)	(376,503)
Accumulated Other Comprehensive (Loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(373,018)	(356,730)	(329,899)	(347,926)
Ending balance	$ (381,809)	$ (348,000)	$ (381,809)	$ (348,000)

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Earnings Per Share [Abstract]
Net income	$ 21,516	$ (3,804)	$ 24,991	$ (62,433)
Weighted Average Common Shares, Basic EPS	39,364	39,190	39,319	39,111
Weighted Average Common Shares, Dilutive effect of nonvested share awards	182	0	178	0
Weighted Average Common Shares, Diluted EPS	39,546	39,190	39,497	39,111
EPS, Basic (in dollars per share)	$ 0.55	$ (0.10)	$ 0.64	$ (1.60)
EPS, Dilutive effect of nonvested share awards (in dollars per share)	(0.01)	0	(0.01)	0
EPS, Diluted (in dollars per share)	$ 0.54	$ (0.10)	$ 0.63	$ (1.60)